Effects of melatonin and bright light administration on motor and sensory symptoms of RLS
- PMID: 20226733
- DOI: 10.1016/j.sleep.2009.12.008
Effects of melatonin and bright light administration on motor and sensory symptoms of RLS
Abstract
Background: A close temporal relationship was shown between the onset of melatonin secretion at night and the worsening of restless legs syndrome (RLS) symptoms, suggesting that melatonin may play a role in the genesis of this phenomenon. To test this hypothesis we studied the effects of the administration of exogenous melatonin and, conversely, the suppression of endogenous melatonin secretion by bright light exposure on the severity of RLS symptoms.
Methods: Eight RLS subjects were studied in three conditions: at baseline, after administration of melatonin and during bright light exposure. The severity of RLS symptoms was assessed by the suggested immobilization test (SIT), which allows quantification of both sensory and motor manifestations (SIT-PLM) of RLS.
Results: Analyses showed a significant increase of SIT-PLM index when subjects received exogenous melatonin compared to both baseline and bright light conditions, but bright light exposure had no effect on leg movements compared to the baseline condition. Analyses also revealed a small but significant decrease in sensory symptoms with bright light exposure compared to baseline.
Conclusion: Exogenous melatonin may have a detrimental effect on motor symptoms, and bright light exposure produced small but significant improvement of leg discomfort. The study shows the interest of using the SIT to measure outcome of intervention in RLS. Further studies will be needed to assess the therapeutic value of bright light in RLS.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Circadian rhythm of restless legs syndrome: relationship with biological markers.Ann Neurol. 2004 Mar;55(3):372-80. doi: 10.1002/ana.10843. Ann Neurol. 2004. PMID: 14991815
-
Test-to-test variability in motor activity during the suggested immobilization test in restless legs patients.Sleep Med. 2006 Oct;7(7):561-6. doi: 10.1016/j.sleep.2006.02.007. Epub 2006 Sep 22. Sleep Med. 2006. PMID: 16996310
-
Restless legs syndrome and near-infrared light: An alternative treatment option.Physiother Theory Pract. 2011 Jul;27(5):345-51. doi: 10.3109/09593985.2010.511440. Epub 2010 Oct 26. Physiother Theory Pract. 2011. PMID: 20977377 Clinical Trial.
-
[Diagnosis and symptom rating scale of restless legs syndrome].Brain Nerve. 2009 May;61(5):533-8. Brain Nerve. 2009. PMID: 19514513 Review. Japanese.
-
[Restless-legs syndrome].Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):701-21. doi: 10.1016/j.neurol.2008.06.006. Epub 2008 Jul 24. Rev Neurol (Paris). 2008. PMID: 18656214 Review. French.
Cited by
-
Why the worsening at rest and worsening at night criteria for Restless Legs Syndrome are listed separately: review of the circadian literature on RLS and suggestions for future directions.Front Neurol. 2023 Apr 27;14:1153273. doi: 10.3389/fneur.2023.1153273. eCollection 2023. Front Neurol. 2023. PMID: 37181571 Free PMC article. Review.
-
Chronic Administration of Melatonin: Physiological and Clinical Considerations.Neurol Int. 2023 Mar 15;15(1):518-533. doi: 10.3390/neurolint15010031. Neurol Int. 2023. PMID: 36976674 Free PMC article. Review.
-
Circadian rhythm in restless legs syndrome.Front Neurol. 2023 Feb 23;14:1105463. doi: 10.3389/fneur.2023.1105463. eCollection 2023. Front Neurol. 2023. PMID: 36908590 Free PMC article. Review.
-
Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease.Antioxidants (Basel). 2023 Feb 6;12(2):396. doi: 10.3390/antiox12020396. Antioxidants (Basel). 2023. PMID: 36829955 Free PMC article. Review.
-
Restless legs syndrome is associated with long-COVID in women.J Clin Sleep Med. 2022 May 1;18(5):1413-1418. doi: 10.5664/jcsm.9898. J Clin Sleep Med. 2022. PMID: 35484639 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical